Takeda Pharmaceutical layoffs, on the record
Every job cut, severance charge and restructuring Takeda Pharmaceutical reported in its annual reports, 2024 to 2026, quoted from the filings.
Job cuts, severance and restructuring
None of Takeda Pharmaceutical’s annual reports for 2024 to 2026 describes a layoff, workforce reduction or restructuring.
Takeda Pharmaceutical has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Takeda Pharmaceutical’s annual reports (20-F for 2026, 20-F for 2025, 20-F for 2024) and the financial data it files with the SEC, as of 2026-06-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.